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Abstract: Three new triterpenoids, 3β-hydroxy-urs-30-p-Z-hydroxycinnamoyl-12-en-28-oic-acid (1), 3β-hydroxy-olean-30-p-E-
hydroxycinnamoyl-12-en-28-oic-acid (2) and 3β,6α-dihydroxy-urs-14-en-12-one (3), together with seven known triterpenoids, were 
isolated from the roots of Rubia schumanniana. Their structures were established by means of spectroscopic analysis. All  
compounds were evaluated for cytotoxic activity, and compounds 2–6 showed cytotoxicity with the IC50 values of 10.75~18.87 
μg/mL. 
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Introduction 
Rubia schumanniana, an endemic species, is mainly  
distributed in southwest China. As one of the substitutes of 
traditional Chinese medicine R. cordifolia, its roots have been 
used for the treatment of tuberculosis, rheumatism, contusion, 
febrility and menoxenia. Previous studies on this plant have 
resulted in the isolation of seven quinions and β-sitosterol.1,2 
As part of our continuing research on chemical constituents of 
medicinal plants from the genus Rubia, a systematic  
phytochemical investigation of the roots of R. schumanniana 
was carried out, which led to the isolation of three new 
triterpenoids (1–3), along with seven known triterpenoids, 
zamanic acid (4),3 maslinic acid (5),4 ursolic acid (6),5  
rubifolic acid (7),6 oleanolic acid (8),7 karachic acid (9),8 and 
rubiarbonol K (10).9 All compounds were evaluated for  
cytotoxicity against three human cancer cell lines (Hela,  
BGC-823, A549). Herein, we report the isolation, structural 
determination, and cytotoxic activities of these compounds. 
 
Results and Discussion 
Compound 1 was obtained as a white powder with a 
positive specific rotation ([α]16D   + 6.5). Its molecular formula, 
C39H54O6, was deduced by HRESIMS (m/z 617.3856 [M – H]–
), indicating 13 degrees of unsaturation. The IR spectrum 
showed absorption bands for hydroxyl (3426 cm–1), carbonyl 
(1689 cm–1) and olefinic (1632 cm–1) groups. The 13C NMR 
spectrum of 1 (Table 1) exhibited 39 carbons, including one 
trisubstituted double bond (δC 126.7, 139.3), one carboxyl (δC 
180.3) and one p-hydroxycinnamoyl group, six methyls, ten 
methylenes (one oxygenated), six methines (one oxygenated), 
and five quaternary carbons. Comparison of the NMR data of 
1 with those of zamanic acid (4) revealed that both compounds 
are ursane-type triterpenoids. The only difference between 
them was that the coupling constant of the disubstituted double 
bond in p-hydroxycinnamoyl group is 13.0 Hz in 1 while 16.0 
Hz in 4. The HMBC correlations of H-30 with the ester 
carbonyl carbon, C-19, C-20, and C-21 enabled the p-Z-
hydroxycinnamoyl group to be placed at C-30 (Figure 1). The 
relative configuration of 1 was deduced from the analysis of 
its ROESY spectrum (Figure 2). The observed NOE 
correlations of H-3/H-5 and Me-23, H-5/H-9, and H-9/Me-27 
indicated that H-3, H-5, H-9, Me-23 and Me-27 are cofacial 
and assigned as α-oriented. In turn the cross-peaks of Me-
25/Me-24 and Me-26, and H-20/H-18 and Me-29 indicated the 
β-oriented of H-18, H-20, Me-24, Me-25, Me-26 and Me-29. 
From the above evidences, the structure of 1 was established 
as 3β-hydroxy-urs-30-p-Z-hydroxycinnamoyl-12-en-28-oic-
acid. 
Compound 2 exhibited the same molecular formula 
C39H54O6 as 1, as established by HREIMS at m/z 618.3890 
[M]+. The NMR data of 2 (Table 1) were similar to those of 
oleanolic acid (8) except for the presence of one p-E-
hydroxycinnamoyl group in the downfield region of 2 and the 
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replacement of one methyl in 8 by one hydroxymethyl group 
(δC 74.9). HMBC correlations of H-30 with the ester carbonyl 
carbon (δC 167.7), C-19, C-20, C-21, and Me-29 indicated that 
the p-E-hydroxycinnamoyl group located at C-30 (Figure 1). 
The observed NOE correlations (Figure 2) of H-3/H-5 and 
Me-23, H-5/H-9, and H-9/Me-27 indicated that H-3, H-5, H-9, 
Me-23 and Me-27 are cofacial and assigned as α-oriented. In 
turn the cross-peaks of Me-25/Me-24 and Me-26, and H-
18/Me-29 indicated the β-oriented of H-18, Me-24, Me-25, 
Me-26 and Me-29. Thus, the structure of 2 was assigned as 3β-
hydroxy-olean-30-p-E-hydroxycinnamoyl-12-en-28-oic-acid. 
Compound 3 gave the molecular formula C30H48O3, based 
on HRESIMS (m/z 479.3504 [M + Na]+), requiring seven 
degrees of unsaturation. The IR spectrum showed absorption 
bands for hydroxyl (3442 cm–1), carbonyl (1705 cm–1) and 
olefinic (1640 cm–1) groups. The 13C NMR spectrum data 
(Table 1) showed the presence of 30 carbon signals due to one 
trisubstituted double bond (δC 119.1, 157.2), one ketone 
carbon (δC 215.8), eight methyls, seven methylenes, seven 
Table 1. 1H NMR and 13C NMR data for compounds 1–3 in pyridine-d5 
pos. 
1 2 3 
δHd (J in Hz) δCa, type δHd (J in Hz) δCb, type δHc (J in Hz) δCa, type
1a 0.98, overlap 39.5, CH2 1.01, overlap 39.0, CH2 1.09, overlap 38.4, CH2 
1b 1.56, overlap 1.54, m 
2a 1.85, overlap 28.6, CH2 1.85, m 28.1, CH2 1.92, m 28.2, CH2 
2b 2.34, m  2.18, m 
3 3.48, dd (10.0, 6.0) 78.6, CH 3.46, m 78.1, CH 3.57, m 78.8, CH 
4 39.9, C 39.4, C 40.6, C 
5 0.86, overlap 56.3, CH 0.87, overlap 55.8, CH 1.34, d (10.6) 61.4, CH
6a 1.37, overlap 19.3, CH2 1.37, m 18.8, CH2 4.43, dt (10.6, 3.6) 68.0, CH 
6b 1.56, overlap 1.56, overlap 
7a 1.37, overlap 34.0, CH2 1.32, overlap 33.3, CH2 1.96, overlap 53.1, CH2 
7b 1.56, overlap 1.49, m 2.58, dd (12.0, 3.6) 
8 40.4, C 39.8, C 42.1, C 
9 1.64, overlap 48.5, CH 1.67, overlap 48.1, CH 2.25, overlap 51.2, CH 
10 37.8, C 37.4, C 40.1, C 
11a 1.97, overlap 24.1, CH2 1.94, m 23.8, CH2 2.48, dd (16.8,11.2) 38.2, CH2 
11b 2.80, dd (16.8, 9.2) 
12 5.51, br. s 126.7, CH 5.56, br. s 123.1, CH 215.8, C
13  139.3, C   139.9, C   54.2, C 
14 42.9, C 42.2, C 157.2, C 
15 2.33, m 29.1, CH2 2.20, m 28.3, CH2 5.75, dd (8.0, 2.0) 119.1, CH 
16a 2.05, overlap 25.3, CH2 2.01, m 23.9, CH2 1.52, overlap 38.1, CH2 
16b 2.14, m 2.18, m 2.13, d (14.8) 
17 48.3, C 47.0, C 35.5, C 
18 2.69, d (11.0) 53.8, CH 3.40, m 41.1, CH 2.25, overlap 49.3, CH 
19 1.85, overlap 34.9, CH 2.06, m 41.1, CH2 1.43, overlap 37.6, CH 
20 1.42, overlap 44.4, CH 35.2, C 1.30, overlap 37.4, CH 
21a 1.62, overlap 26.1, CH2 1.37, m 29.2, CH2 1.05, overlap 29.3, CH2 
21b 1.85, overlap 1.69, m 1.60, m 
22a 1.97, overlap 37.4, CH2 1.90, m 32.3, CH2 1.25, overlap 38.7, CH2 
22b 2.05, overlap 2.09, m 
23 1.26, s 29.3, CH3 1.25, s 28.8, CH3 2.02, s 32.4, CH3 
24 1.04, s 17.1, CH3 1.05, s 16.6, CH3 1.48, s 17.1, CH3 
25 0.90, s 16.2, CH3 0.91, s 15.6, CH3 1.03, s 17.1, CH3 
26 1.07, s 17.9, CH3 1.05, s 17.5, CH3 1.07, s 25.5, CH3 
27 1.22, s 24.4, CH3 1.32, s 26.2, CH3 1.43, s 21.1, CH3 
28 180.3, C 179.9, C 0.88, s 34.0, CH3 
29 1.07, overlap 17.6, CH3 1.19, s 19.5, CH3 1.14, d (6.4) 25.1, CH3 
30a 4.26, dd (11.0, 7.5) 68.2, CH2 4.14, d (10.5) 74.9, CH2 0.97, d (6.4) 22.8, CH3 
30b 4.49, dd (11.0, 3.0) 4.23, d (10.5) 
1' 167.8, C 167.7, C
2' 6.07, d (13.0) 116.9, CH 6.77, d (16.0) 115.3, CH 
3' 7.01, d (13.0) 144.6, CH 8.07, d (16.0) 144.6, CH 
4' 127.1, C 126.3, C 
5' 8.10, d (8.5) 134.1, CH 7.68, d (8.0) 130.8, CH 
6' 7.22, overlap 116.5, CH 7.21, overlap 116.9, CH 
7' 161.1, C 161.7, C 
8' 7.22, overlap 116.5, CH 7.21, overlap 116.9, CH 
9' 8.10, d (8.5) 134.1, CH 7.68, d (8.0) 130.8, CH 
aDate were measured at 100 MHz; bDate were measured at 125 MHz; cDate were measured at 400 MHz; dDate were measured at 500 MHz. 
 
Figure 1.  Key 1H-1H COSY and HMBC correlations of 1–3 
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methines (two oxygenated), and five quaternary carbons. 
Comparison of the NMR data of 3 with those of ursolic acid 
suggested that their structures are closely related.10 The main 
differences were that one characteristic trisubstituted double 
bond at C-12/C-13 in conventional ursane-type triterpenoids 
was absent in 3, while one different trisubstituted double bond, 
one carbonyl group, and one additional hydroxy group were 
present. The double bond was placed between C-14 and C-15, 
as determined by HMBC correlations (Figure 1) of H-15 (δH 
5.75) with C-17 (δC 35.5) and of Me-26 and Me-27 with C-14 
(δC 157.2). The location of the ketone carbon (δC 215.8) at C-
12 was elucidated by HMBC correlations of H-9, H-11 and 
Me-27 with C-12. In addition, the position of the additional 
hydroxy group at C-6 was deduced by correlations of H-6 with 
H-5 in the 1H-1H COSY spectrum combined with HMBC 
correlations of H-5 with C-6 (Figure 1). Thus, the planar 
structure of 3 was established. The α-orientations of H-3, H-5, 
H-9, and Me-23 were established by NOE correlations of H-
3/H-5 and Me-23 and H-5/H-9, and the β-orientations of H-6, 
H-18, H-20, Me-24, Me-25, Me-26, Me-27, Me-28, Me-29 
were deduced by NOE correlations of H-6/Me-24 and Me-25, 
H-7β/H-6 and Me-26, H-18/Me-27, Me-28 and Me-29, and 
Me-29/H-20 (Figure 2). Accordingly, the structure of 3 was 
elucidated as 3β, 6α-dihydroxy-urs-14-en-12-one. 
All compounds were evaluated for cytotoxicity against three 
human cancer cell lines, Hela (human cervical carcinoma), 
BGC-823 (human stomach adenocarcinoma), and A549  
(human lung adenocarcinoma), and results indicated that  
compounds 2–6 showed cytotoxicity with the IC50 values of 
10.75~18.87 μg/mL (Table 2). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a Horiba SEPA-300 polarimeter. IR spectra 
were obtained by a Bruker FT-IR Tensor 27 spectrophotometer
using KBr pellets. UV spectra were obtained using a Shimadzu 
UV-2401A spectrophotometer. 1D and 2D NMR spectra were 
recorded on Bruker AX-400, DRX-500, or AV-600  
spectrometers with TMS as an internal standard. Chemical 
shifts (δ) were expresses in ppm with reference to solvent  
signals. HREIMS were recorded on a Waters Auto Premier 
P776 spectrometer. HRESIMS were recorded on an API 
QSTER time-of-flight spectrometer. Analytical or  
Semipreparative HPLC was performed on an Agilent 1100 
liquid chromatograph with a Zorbax Eclipse-C18 (4.6 mm × 
150 mm; 9.4 mm × 250 mm) column. Cloumn chroma-
tographies were performed using silica gel (200–300 mesh, 
Qingdao Yu-Ming-Yuan Chemical Co. Ltd., Qingdao, China), 
Sephadex LH-20 (Pharmacia Fine Chemical Co., Uppsala, 
Sweden), and Lichroprep RP-18 gel (40–63 μM, Merck, 
Darmstadt, Germany). Fractions were monitored by TLC (GF 
254, Qingdao Yu-Ming-Yuan Chemical Co. Ltd., Qingdao, 
China), and spots were visualized by heating silica gel plates 
sprayed with 10% H2SO4 in EtOH. 
 
Plant Materal. The roots of R. schumanniana were  
purchased in August 2009 from the Yunnan Lv-Sheng  
Pharmaceutical Co. Ltd., Kunming, China. The material was 
identified by Prof. Xi-Wen Li of Kunming Institute of Botany. 
A voucher specimen (KUN0328859) was deposited at the 
Herbarium of Kunming Institute of Botany, Chinese Academy 
of Sciences. 
 
Extraction and Isolation. The dried and powdered roots of 
R. schumanniana (50 kg) were extracted with 70% aqueous 
MeOH (40 L × 3) for 12 hours at room temperature. After 
removal of the solvent under reduced pressure, the MeOH 
extract (18.6 kg) was suspended in H2O and partitioned  
successively with EtOAc and n-BuOH to give an EtOAc-
soluble portion (3.7 kg) and a n-BuOH-soluble portion (4.2 
kg). The EtOAc part was chromatographed on silica gel  
column eluting with chloroform-methanol (1:0, 95:5, 9:1, 8:2, 
7:3, and 0:1) to afford fractions I–IV. Fraction I (9:1, 163 g) 
was further chromatographed on silica gel using a petroleum 
ether-acetone gradient (10:1 to 0:1) as the eluent to yield 6 
subfractions, I-1–I-6. Subfractions I-1 was chromatographed 
with RP-18, and then separated by semi-preparative HPLC 
(CH3CN:H2O, 80:20) to yield 1 (12 mg) and 2 (2.6 mg). 4 (23 
mg) was purified from subfractions I-2 by repeated chromato-
graphed with silica gel. Subfractions I-4 was chromatographed 
on silica gel using a chloroform-methanol gradient (50:1 to 
10:1) as the eluent, and then purified over Sephadex LH-20 
eluted with chloroform-methanol (1:1), then by semi-
preparative HPLC (CH3CN:H2O, 60:40 and 73:27) to yield 5 
(22 mg), 6 (8 mg), 8 (35 mg) and 3 (7 mg), respectively.  
Subfractions I-6 was chromatographed on silica gel using a 
Table 2. Cytotoxicity of 1–10 against cancer cell linesa with 
IC50 (μg/mL) 
compound Hela A549 BGC-823 
1 > 20 > 20 > 20 
2 16.18 >20 > 20 
3 > 20 15.74 > 20 
4 13.53 > 20 14.18 
5 12.39 18.87 10.75 
6 11.80 >20 11.89 
7 > 20 > 20 > 20 
8 > 20 > 20 > 20
9 > 20 > 20 > 20 
10 > 20 > 20 > 20 
Taxolb 0.38 0.02 0.01 
aCell lines: Hela human cervical carcinoma; BGC-823 human 





































Figure 2.  Key ROESY correlations of 1–3 
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chloroform-acetone gradient (50:1 to 0:1) as the eluent, and 
then purified by semi-preparative HPLC (CH3CN:H2O, 65:35) 
to yield 7 (15 mg), 9 (10.2 mg) and 10 (6 mg). 
 
3β-Hydroxy-urs-30-p-Z-hydroxycinnamoyl-12-en-28-oic-
acid (1): white powder; [α]16D   + 6.5 (c 0.08, MeOH:CHCl3 = 
1:1); UV (MeOH) max (log ) 202 (4.16), 312 (4.14) nm; IR 
(KBr) max 3426, 2965, 2937, 2873, 1689, 1632, 1606, 1514, 
1456, 1377, 1311, 1277, 1258, 1202, 1184, 1029, 997, 833, 
519 cm–1; 1H and 13C NMR data, see Table 1; negative ESIMS 
m/z 617 [M – H]–; negative HRESIMS m/z 617.3856 [M – H]– 
(calcd for C39H53O6, 617.3842). 
 
3β-Hydroxy-olean-30-p-E-hydroxycinnamoyl-12-en-28-
oic-acid (2): white amorphous powder; [α]16D   + 13.1 (c 0.13, 
MeOH); UV (MeOH) λmax (log ) 202 (4.16), 227 (4.01), 313 
(4.22) nm; IR (KBr) max 3429, 2938, 2875, 1692, 1632, 1606, 
1515, 1456, 1387, 1167, 1027, 996, 833, 519 cm–1; 1H and 13C 
NMR data, see Table 1; positive EIMS m/z 618 [M]+; positive 
HREIMS m/z 618.3890 [M]+ (calcd for C39H54O6, 618.3920). 
 
3β, 6α-Dihydroxy-urs-14-en-12-one (3): white amorphous 
powder; [α]20D   – 10.7 (c 0.10, MeOH); UV (MeOH) λmax (log ) 
201 (3.41) nm; IR (KBr) max 3442, 2927, 2866, 1705, 1640, 
1462, 1382, 1140, 1036, 987 cm–1; 1H and 13C NMR data, see 
Table 1; positive ESIMS m/z 479 [M + Na]+; positive 
HRESIMS m/z 479.3504 [M + Na]+ (calcd for C30H48O3Na, 
479.3501). 
 
Cytotoxicity Assay. The cytotoxicity of all compounds 
against Hela, A549, and BGC-823 cancer cell lines was  
measured using the sulforhodamine B (SRB) assay. Taxol was 
used as positive control. Cells were plated in 96-well culture 
plates for 24h before treated with serial dilutions of all  
compounds. After being incubated for 48 h, cells were fixed 
with 25 μL of ice-cold 50% trichloroacetic acid and incubated 
at 4 OC for 1 h. After washing with distilled water and air-
drying, the plate was stained for 15 min with 100 μL of 0.4% 
SRB (Sigma) in 1% glacial acetic acid. The plates were 
washed with 1% acetic acid and air-dried. For reading the 
plate, the protein-bound dye was dissolved in 100 μL of 10 
mM Tris base. The absorbance was measured at 560 nm. All 
tests were performed in triplicate, and results are expressed as 
IC50 values. 
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